Terkko Navigator / Ylikorkala, O.

Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland

Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study

Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse

Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy

Increased cardiac and stroke death risk in the first year after discontinuation of postmenopausal hormone therapy

Vasomotor hot flashes and cardiac repolarization: a randomized placebo-controlled trial of postmenopausal hormone therapy

New evidence for cardiac benefit of postmenopausal hormone therapy

Lower Death Risk for Vascular Dementia Than for Alzheimer's Disease With Postmenopausal Hormone Therapy Users

Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use

Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study

Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies

Vaginal estradiol use and the risk for cardiovascular mortality

Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy

The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study

Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma

Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality

Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative

Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative

Postmenopausal hot flushes and bone mineral density: a longitudinal study

Premenstrual symptoms in fertile age are associated with impaired quality of life, but not hot flashes, in recently postmenopausal women

Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy

Sex differences in age-related cardiovascular mortality

Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland

Smoking is accompanied by a suppressed cervical nitric oxide release in women with high-risk human papillomavirus infection

Decreasing perinatal mortality in placental abruption

Menopausal hot flashes and insulin resistance

Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study

Primary fallopian tube carcinoma risk in users of postmenopausal hormone therapy in Finland

Effect of hot flushes on cardiovascular autonomic responsiveness: a randomized controlled trial on hormone therapy

High-risk human papillomavirus-induced expression of endothelial and inducible nitric oxide synthase in human uterine cervix

A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland

Hormone therapy and vasomotor symptoms

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer

Plasma nitrite/nitrate levels in women with postmenopausal hot flushes

Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy

Cervical nitric oxide release in Chlamydia trachomatis and high-risk human papillomavirus infection

Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas

Hormone therapy and risk for breast cancer in Finnish postmenopausal women

Cardiovascular autonomic responsiveness in postmenopausal women with and without hot flushes

Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study

Menopausal hot flushes and vascular health

Cervical nitric oxide release and persistence of high-risk human papillomavirus in women

Self-reported smoking habits and serum cotinine levels in women with placental abruption

Per Bergsjö, in memoriam

Endometriosis and assisted reproduction techniques

Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy

Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy

Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently post-menopausal women

Male fetal sex is associated with earlier onset of placental abruption